399 related articles for article (PubMed ID: 15466923)
1. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.
Barker JN; Weisdorf DJ; DeFor TE; Blazar BR; McGlave PB; Miller JS; Verfaillie CM; Wagner JE
Blood; 2005 Feb; 105(3):1343-7. PubMed ID: 15466923
[TBL] [Abstract][Full Text] [Related]
2. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
3. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
4. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia.
Jaing TH; Yang CP; Hung IJ; Chen SH; Sun CF; Chow R
Bone Marrow Transplant; 2007 Aug; 40(4):307-11. PubMed ID: 17572710
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
7. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.
Brunstein CG; Barker JN; Weisdorf DJ; Defor TE; McKenna D; Chong SY; Miller JS; McGlave PB; Wagner JE
Bone Marrow Transplant; 2009 Jun; 43(12):935-40. PubMed ID: 19139736
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults.
Hamza NS; Lisgaris M; Yadavalli G; Nadeau L; Fox R; Fu P; Lazarus HM; Koc ON; Salata RA; Laughlin MJ
Br J Haematol; 2004 Feb; 124(4):488-98. PubMed ID: 14984500
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
Wagner JE; Barker JN; DeFor TE; Baker KS; Blazar BR; Eide C; Goldman A; Kersey J; Krivit W; MacMillan ML; Orchard PJ; Peters C; Weisdorf DJ; Ramsay NK; Davies SM
Blood; 2002 Sep; 100(5):1611-8. PubMed ID: 12176879
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units.
Yin Y; Ren HY; Cen XA; Qiu ZX; Ou JP; Wang WS; Wang MJ; Xu WL; Wang LH; Li Y; Dong YJ
Chin Med J (Engl); 2011 Aug; 124(16):2411-6. PubMed ID: 21933579
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.
Kindwall-Keller TL; Hegerfeldt Y; Meyerson HJ; Margevicius S; Fu P; van Heeckeren W; Lazarus HM; Cooper BW; Gerson SL; Barr P; Tse WW; Curtis C; Fanning LR; Creger RJ; Carlson-Barko JM; Laughlin MJ
Bone Marrow Transplant; 2012 Jul; 47(7):924-33. PubMed ID: 22002488
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
Laughlin MJ; Barker J; Bambach B; Koc ON; Rizzieri DA; Wagner JE; Gerson SL; Lazarus HM; Cairo M; Stevens CE; Rubinstein P; Kurtzberg J
N Engl J Med; 2001 Jun; 344(24):1815-22. PubMed ID: 11407342
[TBL] [Abstract][Full Text] [Related]
14. Cord blood transplantation for adult patients with hematological malignancies.
Yamane T; Nakamae H; Hasegawa T; Terada Y; Hagihara K; Ohta K; Hino M
Osaka City Med J; 2005 Dec; 51(2):83-8. PubMed ID: 16617685
[TBL] [Abstract][Full Text] [Related]
15. Impact of HLA in cord blood transplantation outcomes.
Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
[TBL] [Abstract][Full Text] [Related]
18. Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies.
Moscardó F; Sanz J; Carbonell F; Sanz MA; Larrea L; Montesinos P; Lorenzo I; Vera B; Boluda B; Salazar C; Cañigral C; Planelles D; Jarque I; Solves P; Martín G; López F; de la Rubia J; Martínez J; Carpio N; Martínez-Cuadrón D; Puig N; Montoro JA; Roig R; Sanz GF
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1744-50. PubMed ID: 25008329
[TBL] [Abstract][Full Text] [Related]
19. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.
Sobol U; Go A; Kliethermes S; Bufalino S; Rodriguez T; Smith S; Parthasarathy M; Stiff P
Bone Marrow Transplant; 2015 Dec; 50(12):1519-25. PubMed ID: 26367229
[TBL] [Abstract][Full Text] [Related]
20. Umbilical cord blood transplantation in hematologic diseases in patients over 15 years old: long-term experience at the Pontificia Universidad Católica de Chile.
Ramirez P; Nervi B; Bertin P; Poggi H; Lagos M; Selman C; Pizarro I; Jara V; Wiestruck A; Barriga F
Transplant Proc; 2013; 45(10):3734-9. PubMed ID: 24315012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
